Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome

M. Teresa De la Morena, Jennifer L. Eitson, Igor M. Dozmorov, Serkan Belkaya, Ashley R. Hoover, Esperanza Anguiano, M. Virginia Pascual, Nicolai S C van Oers

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Patients with 22q11.2 deletion syndrome have heterogeneous clinical presentations including immunodeficiency, cardiac anomalies, and hypocalcemia. The syndrome arises from hemizygous deletions of up to 3. Mb on chromosome 22q11.2, a region that contains 60 genes and 4 microRNAs. MicroRNAs are important post-transcriptional regulators of gene expression, with mutations in several microRNAs causal to specific human diseases. We characterized the microRNA expression patterns in the peripheral blood of patients with 22q11.2 deletion syndrome (n = 31) compared to normal controls (n = 22). Eighteen microRNAs had a statistically significant differential expression (p. <0.05), with miR-185 expressed at 0.4. × normal levels. The 22q11.2 deletion syndrome cohort exhibited microRNA expression hyper-variability and group dysregulation. Selected microRNAs distinguished patients with cardiac anomalies, hypocalcemia, and/or low circulating T cell counts. In summary, microRNA profiling of chromosome 22q11.2 deletion syndrome/DiGeorge patients revealed a signature microRNA expression pattern distinct from normal controls with clinical relevance.

Original languageEnglish (US)
Pages (from-to)11-22
Number of pages12
JournalClinical Immunology
Volume147
Issue number1
DOIs
StatePublished - Apr 2013

Fingerprint

DiGeorge Syndrome
MicroRNAs
Hypocalcemia
Chromosome Deletion
Regulator Genes
Cell Count
Chromosomes
T-Lymphocytes
Gene Expression
Mutation

Keywords

  • 22q11.2 deletion syndrome
  • DiGeorge syndrome
  • MicroRNA profiling
  • MiR-185
  • Primary immunodeficiency disease

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome. / De la Morena, M. Teresa; Eitson, Jennifer L.; Dozmorov, Igor M.; Belkaya, Serkan; Hoover, Ashley R.; Anguiano, Esperanza; Pascual, M. Virginia; van Oers, Nicolai S C.

In: Clinical Immunology, Vol. 147, No. 1, 04.2013, p. 11-22.

Research output: Contribution to journalArticle

De la Morena, M. Teresa ; Eitson, Jennifer L. ; Dozmorov, Igor M. ; Belkaya, Serkan ; Hoover, Ashley R. ; Anguiano, Esperanza ; Pascual, M. Virginia ; van Oers, Nicolai S C. / Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome. In: Clinical Immunology. 2013 ; Vol. 147, No. 1. pp. 11-22.
@article{dafb5067ddbb401dad5eba0a27d402d2,
title = "Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome",
abstract = "Patients with 22q11.2 deletion syndrome have heterogeneous clinical presentations including immunodeficiency, cardiac anomalies, and hypocalcemia. The syndrome arises from hemizygous deletions of up to 3. Mb on chromosome 22q11.2, a region that contains 60 genes and 4 microRNAs. MicroRNAs are important post-transcriptional regulators of gene expression, with mutations in several microRNAs causal to specific human diseases. We characterized the microRNA expression patterns in the peripheral blood of patients with 22q11.2 deletion syndrome (n = 31) compared to normal controls (n = 22). Eighteen microRNAs had a statistically significant differential expression (p. <0.05), with miR-185 expressed at 0.4. × normal levels. The 22q11.2 deletion syndrome cohort exhibited microRNA expression hyper-variability and group dysregulation. Selected microRNAs distinguished patients with cardiac anomalies, hypocalcemia, and/or low circulating T cell counts. In summary, microRNA profiling of chromosome 22q11.2 deletion syndrome/DiGeorge patients revealed a signature microRNA expression pattern distinct from normal controls with clinical relevance.",
keywords = "22q11.2 deletion syndrome, DiGeorge syndrome, MicroRNA profiling, MiR-185, Primary immunodeficiency disease",
author = "{De la Morena}, {M. Teresa} and Eitson, {Jennifer L.} and Dozmorov, {Igor M.} and Serkan Belkaya and Hoover, {Ashley R.} and Esperanza Anguiano and Pascual, {M. Virginia} and {van Oers}, {Nicolai S C}",
year = "2013",
month = "4",
doi = "10.1016/j.clim.2013.01.011",
language = "English (US)",
volume = "147",
pages = "11--22",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome

AU - De la Morena, M. Teresa

AU - Eitson, Jennifer L.

AU - Dozmorov, Igor M.

AU - Belkaya, Serkan

AU - Hoover, Ashley R.

AU - Anguiano, Esperanza

AU - Pascual, M. Virginia

AU - van Oers, Nicolai S C

PY - 2013/4

Y1 - 2013/4

N2 - Patients with 22q11.2 deletion syndrome have heterogeneous clinical presentations including immunodeficiency, cardiac anomalies, and hypocalcemia. The syndrome arises from hemizygous deletions of up to 3. Mb on chromosome 22q11.2, a region that contains 60 genes and 4 microRNAs. MicroRNAs are important post-transcriptional regulators of gene expression, with mutations in several microRNAs causal to specific human diseases. We characterized the microRNA expression patterns in the peripheral blood of patients with 22q11.2 deletion syndrome (n = 31) compared to normal controls (n = 22). Eighteen microRNAs had a statistically significant differential expression (p. <0.05), with miR-185 expressed at 0.4. × normal levels. The 22q11.2 deletion syndrome cohort exhibited microRNA expression hyper-variability and group dysregulation. Selected microRNAs distinguished patients with cardiac anomalies, hypocalcemia, and/or low circulating T cell counts. In summary, microRNA profiling of chromosome 22q11.2 deletion syndrome/DiGeorge patients revealed a signature microRNA expression pattern distinct from normal controls with clinical relevance.

AB - Patients with 22q11.2 deletion syndrome have heterogeneous clinical presentations including immunodeficiency, cardiac anomalies, and hypocalcemia. The syndrome arises from hemizygous deletions of up to 3. Mb on chromosome 22q11.2, a region that contains 60 genes and 4 microRNAs. MicroRNAs are important post-transcriptional regulators of gene expression, with mutations in several microRNAs causal to specific human diseases. We characterized the microRNA expression patterns in the peripheral blood of patients with 22q11.2 deletion syndrome (n = 31) compared to normal controls (n = 22). Eighteen microRNAs had a statistically significant differential expression (p. <0.05), with miR-185 expressed at 0.4. × normal levels. The 22q11.2 deletion syndrome cohort exhibited microRNA expression hyper-variability and group dysregulation. Selected microRNAs distinguished patients with cardiac anomalies, hypocalcemia, and/or low circulating T cell counts. In summary, microRNA profiling of chromosome 22q11.2 deletion syndrome/DiGeorge patients revealed a signature microRNA expression pattern distinct from normal controls with clinical relevance.

KW - 22q11.2 deletion syndrome

KW - DiGeorge syndrome

KW - MicroRNA profiling

KW - MiR-185

KW - Primary immunodeficiency disease

UR - http://www.scopus.com/inward/record.url?scp=84874530655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874530655&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2013.01.011

DO - 10.1016/j.clim.2013.01.011

M3 - Article

C2 - 23454892

AN - SCOPUS:84874530655

VL - 147

SP - 11

EP - 22

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 1

ER -